Freenome Inc. (FRNM) valuation against sector peers: P/S 30.2.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.

Metric	FRNM	Sector median	vs median
P/E	—	29.1 · n=156	—
P/B	—	3.8 · n=306	—
P/S	30.2	4.1 · n=299	639% above
EV/EBIT	—	25.9 · n=143	—
Free-cash-flow yield	—	1.5% · n=288	—
Dividend yield	0.00%	0.00% · n=361	—
Return on equity	—	−2.7% · n=305	—
Return on invested capital	—	0.4% · n=278	—
Gross margin	—	63.1% · n=204	—
Net debt / EBITDA	—	1.24 · n=148	—

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.

Value factor: 20 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

Instrument	P/E	P/B	EV/EBIT	Free-cash-flow yield	Dividend yield	Smart Score
LLYEli Lilly & Co	46.6	31.9	—	1.5%	0.6%	6/10
JNJJohnson & Johnson	40.7	8.0	—	3.1%	1.9%	8/10
ABBVAbbVie	49.5	—	27.3	3.7%	3.0%	6/10
MRKMerck	147.7	8.1	—	4.1%	2.3%	8/10
UNHUnitedHealth	22.3	3.4	17.0	6.4%	2.3%	10/10
TMOThermo Fisher Scientific	35.5	4.6	33.8	3.0%	0.3%	9/10
AMGNAmgen	26.5	17.3	23.0	3.8%	2.2%	8/10
GILDGilead Sciences	—	15.9	—	6.6%	1.9%	4/10
ABTAbbott	41.9	3.9	33.7	3.4%	2.7%	6/10
PFEPfizer	42.2	1.9	—	6.9%	7.2%	1/10

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Jun 2026 · filed 15 Jul 2026

Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.

Cookie settings